CAS No. |
2654026-13-6 |
|---|---|
中文名称 |
AKT抑制剂IN-8 |
英文名称 |
AKT-IN-8 |
别名 |
AKT-IN-8 |
标准英文名 |
(7aS,9R)-9-amino-N-((S)-1-(4-chlorophenyl)-3-hydroxypropyl)-7,7a,8,9,10,11-hexahydro-4H-6-oxa-1,3,4,11a-tetraazadibenzo[cd,f]azulene-9-carboxamide |
分子式 |
C22H25ClN6O3 |
分子量 |
456.93 |
精确分子量 |
456.17 |
SMILES |
O=C([C@](CC1)(N)C[C@]2([H])N1C3=C4C(NC=C4OC2)=NC=N3)N[C@H](C5=CC=C(Cl)C=C5)CCO |
标准SMILES |
N[C@]1(C[C@H]2COC3=CNC4=NC=NC(=C34)N2CC1)C(=O)N[C@@H](CCO)C1C=CC(Cl)=CC=1 |
用途 |
AKT-IN-8 is a potent AKT inhibitor used for targeting AKT1, AKT2, and AKT3 in research related to cancer and other diseases involving the PI3K/AKT signaling pathway. |
InChIKey |
AWLFPOHXSPBHQB-PONJGIIJSA-N |
|
|
评论 |
|---|